Original Research October 15, 2004

The Effect of Clozapine on Factors Controlling Glucose Homeostasis

Oliver D. Howes, MRCPsych; Fiona P. Gaughran, FRCPI, MRCPsych, MD; Stephanie A. Amiel, BSc, MD, FRCP; Robin M. Murray, FRCPsych, DSc; Lyn S. Pilowsky, MRCPsych, PhD

J Clin Psychiatry 2004;65(10):1352-1355

Article Abstract

Background: This prospective study examines the effect of clozapine on factors determining glucose homeostasis.

Method: The sample consisted of all patients meeting DSM-IV criteria for schizophrenia who commenced clozapine treatment within the South London and Maudsley hospitals during 1 year (2000-2001). Growth hormone (GH), insulin-like growth factor-1 (IGF-1), and IGF binding protein-1 (IGFBP-1) were measured in 19 patients (10 female; mean age = 31.1 years [SD = 5.8]; 9 black British/African, 10 white British) before and after a mean of 2.5 (SD = 0.9) months of clozapine treatment.

Results: Baseline IGFBP-1 was low. IGFBP-1, GH, and IGF-1 were not significantly changed by clozapine treatment.

Conclusions: Clozapine does not alter GH, IGF-1, or IGFBP-1 within 3 months of commencing treatment, indicating that alteration in glucose tolerance associated with clozapine treatment involves other mechanisms yet to be elucidated. Baseline abnormalities in IGFBP-1 indicate a preexisting susceptibility to glucoregulatory dysfunction.

Continue Reading...

Did you know members enjoy unlimited free PDF downloads as part of their subscription? Subscribe today for instant access to this article and our entire library in your preferred format. Alternatively, you can purchase the PDF of this article individually.

Subscribe Now

Already a member? Login

Purchase PDF for $40.00

Members enjoy free PDF downloads on all articles. Join today